Tarceva Forecast

NEW YORK, June 19, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Tarceva Forecast

http://www.reportlinker.com/p02162048/Tarceva-Forecast.html

The BCC Research Tarceva Forecast is a quantitative forecast model in an easily accessible Microsoft Excel spreadsheet, segmented by specific parameters.

The introductory sample of the Tarceva Forecast Model was already sent in the update earlier today. I have attached it again for your reference.

The model features:

- Market demand forecasts for Tarceva annually for the years 2010 to 2030 by volume (number of patients) and value (in U.S. dollars)

- Segmentation of volume and value for the following regions: U.S., Japan, Europe, Latin America, China, Asia, Middle East

- Patient volumes, with forecasts by causal factors including population by age range, smoker data, and prevalence

Click here to view a data sheet of the Tarceva Forecast Model.

Use the BCC Research Tarceva Forecast to:

- Examine forecasted market demand for Tarceva: competitor assessment; market opportunity assessment- Identify new business and investment opportunities for products in the lung cancer segment- Validate other Tarceva market-demand data to which you have access

Tarceva Forecast, a strategic investment product designed to provide critical market data for the pharmaceutical cancer drug Tarceva.

Tarveca (Astellas Pharma) is a once-daily, oral, non-chemotherapy prescription drug for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC). Some clinical studies have shown superior patient outcomes from use of Tarceva as a second-line treatment for NSCLC. Starting in 2020, Tarceva begins to lose patent protection in numerous countries.

Through Tarceva Forecast, BCC Research provides high-quality intelligence for strategic decision-making regarding future participation in this large and important market. Market players can use Tarceva Forecast to examine forecasted market demand for Tarceva, identify new business and investment opportunities for related products and services, and validate other Tarceva market-demand data.

Tarceva Forecast is a quantitative forecast model in an easily accessible Microsoft Excel spreadsheet, segmented by specific parameters, featuring market demand forecasts for Tarceva annually for the years 2010 to 2030 by volume and value. Data transparency and sources are disclosed for patient volumes, with forecasts by causal factors including population by age range, smoker data, and prevalence, as well as for population estimates at the country level and product pricing and currency valuation forecasts. Information is segmented by the following regions:  United States, Japan, Europe, Latin America, China, Asia, Middle East.

Table of Contents

Figure 1 Summary Graphs - Value in U.S.D. and Patient Volumes, by Region, 2010-2030

Table 1 Total Market - Value in U.S.D. and Patient Volumes, by Region, 2010-2030

Table 2 United States Patient Volumes, 2010-2030

Table 3 Europe Patient Volumes, 2010-2030

Table 4 Japan Patient Volumes, 2010-2030

Table 5 China Patient Volumes, 2010-2030

Table 6 Asia Patient Volumes, 2010-2030

Table 7 Africa/Oceania Patient Volumes, 2010-2030

Table 8 Middle East Patient Volumes, 2010-2030

Table 9 Americas Patient Volumes, 2010-2030

Table 10 United States Population by age range, 2010-2030

Table 11 Europe Population by Country, 2010-2030

Table 12 Japan Population, 2010-2030

Table 13 China Population, 2010-2030

Table 14 Asia Population by Country, 2010-2030

Table 15 Africa/Oceania Population by Country, 2010-2030

Table 16 Middle East Population by Country, 2010-2030

Table 17 Americas Population by Country, 2010-2030

Table 18 United States Smoker Data

Table 19 Europe Smoker Data by Country

Table 20 Japan Smoker Data

Table 21 China Smoker Data

Table 22 Asia Smoker Data by Country

Table 23 Africa/Oceania Smoker Data by Country

Table 24 Middle East Smoker Data by Country

Table 25 Americas Smoker Data by Country

Table 26 United States Lung Cancer Data, 1975-2010

Table 27 Global Lung Cancer Data, by Male and Female, by Region

Table 28 United States Pricing, Tarceva Annual Cost

Table 29 Europe Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014

Table 30 Japan Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014

Table 31 China Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014

Table 32 Asia Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014

Table 33 Africa/Oceania Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014

Table 34 Middle East Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014

Table 35 Americas Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014

To order this report: Tarceva Forecast http://www.reportlinker.com/p02162048/Tarceva-Forecast.html

__________________________
Contact Clare: clare@reportlinker.comUS: (339)-368-6001Intl: +1 339-368-6001

SOURCE Reportlinker



RELATED LINKS
http://www.reportlinker.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.